About SNDX Dividend Returns
Syndax Pharmaceuticals, Inc. (SNDX) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.
How We Calculate Total Return
Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.
Frequently Asked Questions
Q1What is the total return of SNDX over the past year?
Syndax Pharmaceuticals, Inc. (SNDX) delivered a return of 38.81% over the past year. Since SNDX does not currently pay dividends, the total return equals the price-only return.
Q2How much would $10,000 invested in SNDX be worth today?
A $10,000 investment in Syndax Pharmaceuticals, Inc. one year ago would be worth $13,881 today, representing a gain of $3,881.
Q3Does SNDX pay dividends?
Syndax Pharmaceuticals, Inc. (SNDX) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For SNDX, the total return equals the price-only return.
Q4Did SNDX beat the S&P 500?
Yes, Syndax Pharmaceuticals, Inc. (SNDX) outperformed the S&P 500 by 23.36 percentage points over the past year. SNDX delivered a total return of 38.81%, compared to the S&P 500's 15.45%. This 23.36pp alpha means investors in SNDX earned more than a passive S&P 500 index fund.
Q5What is SNDX's worst drawdown?
Syndax Pharmaceuticals, Inc. (SNDX) experienced a maximum drawdown of -44.18% over the past year, declining from its peak on 2025-02-28 to its trough on 2025-07-07. The stock recovered to its prior peak by 2025-08-15. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.
Q6What is SNDX's long-term total return over 10, 20, or 30 years?
Syndax Pharmaceuticals, Inc. (SNDX) has delivered strong long-term returns with dividends reinvested. Over 10 years, the total return is 80.9% (6.1% CAGR) — $10,000 would have grown to $18,092. Over 20 years: 80.9% total return (3.0% CAGR) — $10,000 → $18,092. Over 30 years: 80.9% total return (2.0% CAGR) — $10,000 → $18,092. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.
Q7What was SNDX's best and worst year?
Syndax Pharmaceuticals, Inc.'s best calendar year was 2020 with a total return of 153.6%. Its worst year was 2018 with a total return of -49.3%. This range shows the volatility investors should expect — the difference between the best and worst year is 202.9 percentage points.
Find the Best Dividend Stocks
Screen for dividend stocks with the highest total returns (including DRIP).